Stock Events

Stock Events

Bioqual 

$37.51
8
+$0.56+1.52% Monday 20:00

Statistics

Day High
37.51
Day Low
37.51
52W High
55
52W Low
33
Volume
-
Avg. Volume
-
Mkt Cap
33.53M
P/E Ratio
15.83
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Oct 24
$0.5
Oct 23
$0.5
Oct 22
$1
Oct 21
$1.25
Oct 20
$1.1
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19JanExpected
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
Q4 2022
0.96
1.43
1.9
2.37
Expected EPS
N/A
Actual EPS
N/A

Financials

-2.14%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
97.74MRevenue
-2.1MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIOQ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charles River Laboratories International
CRL
Mkt Cap9.07B
Charles River Laboratories provides a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, directly competing with BIOQ's research services.
Illumina
ILMN
Mkt Cap20.57B
Illumina offers genomics solutions, including sequencing, which competes with BIOQ's services in genetic analysis and molecular biology research.
IQVIA
IQV
Mkt Cap29.95B
IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry, competing with BIOQ in drug development services.
Icon Energy
ICON
Mkt Cap3.44M
ICON plc offers clinical research services to pharmaceutical, biotechnology, and medical device industries, competing with BIOQ in the field of clinical trials and drug development.
Medpace
MEDP
Mkt Cap14.87B
Medpace is a full-service clinical contract research organization (CRO), offering phase I-IV clinical development services to the pharmaceutical and biotech industries, competing with BIOQ's research services.

About

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Show more...
CEO
Dr. Hanne Andersen-Elyard Ph.D.
Employees
278
Country
United States
ISIN
US09065J1016

Listings

OTC Link
US
BIOQ

0 Comments

Share your thoughts

FAQ

What is Bioqual stock price today?▼
The current price of BIOQ is $37.51 USD — it has increased by +1.52% in the past 24 hours. Watch Bioqual stock price performance more closely on the chart.
What is Bioqual stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioqual stocks are traded under the ticker BIOQ.
What is Bioqual market cap?▼
Today Bioqual has the market capitalization of 33.53M
What is Bioqual revenue for the last year?▼
Bioqual revenue for the last year amounts to 97.74M USD.
What is Bioqual net income for the last year?▼
BIOQ net income for the last year is -2.1M USD.
Does Bioqual pay dividends?▼
Yes, BIOQ dividends are paid annual. The last dividend per share was 0.5 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bioqual have?▼
As of April 20, 2026, the company has 278 employees.
In which sector is Bioqual located?▼
Bioqual operates in the Health & Wellness sector.
When did Bioqual complete a stock split?▼
Bioqual has not had any recent stock splits.
Where is Bioqual headquartered?▼
Bioqual is headquartered in Rockville, United States.